NEW YORK (Reuters) - AVI BioPharma Inc's shares could get a boost if its drug targeting treatment for a rare fatal form of muscular dystrophy proves to be effective in clinical drug trials, according...
Source: http://feeds.reuters.com/~r/reuters/globalmarketsNews/~3/WevZyp6fgqM/us-avi-shares-idUSBRE8300BK20120401
summit news sports news make money online money save money travel cheap
No comments:
Post a Comment